Name | Number of supported studies | Average coverage | |
---|---|---|---|
CD16-negative, CD56-bright natural killer cell, human | 5 studies | 32% ± 4% | |
natural killer cell | 4 studies | 22% ± 4% | |
GABAergic neuron | 3 studies | 22% ± 3% | |
glutamatergic neuron | 3 studies | 37% ± 5% |
Insufficient scRNA-seq data for expression of SPTSSB at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 89% | 1188.00 | 218 / 245 | 78% | 18.59 | 392 / 502 |
bladder | 67% | 1877.95 | 14 / 21 | 59% | 52.76 | 299 / 504 |
brain | 71% | 553.60 | 1889 / 2642 | 47% | 4.51 | 333 / 705 |
ureter | 0% | 0 | 0 / 0 | 100% | 101.95 | 1 / 1 |
stomach | 65% | 896.77 | 232 / 359 | 35% | 6.49 | 100 / 286 |
esophagus | 36% | 249.85 | 527 / 1445 | 55% | 10.05 | 100 / 183 |
breast | 20% | 71.07 | 91 / 459 | 68% | 27.76 | 756 / 1118 |
pancreas | 2% | 4.77 | 6 / 328 | 80% | 15.78 | 142 / 178 |
skin | 72% | 2728.77 | 1304 / 1809 | 6% | 0.70 | 30 / 472 |
uterus | 6% | 22.12 | 11 / 170 | 51% | 16.89 | 233 / 459 |
lung | 0% | 0.42 | 1 / 578 | 39% | 7.25 | 452 / 1155 |
intestine | 0% | 0.83 | 2 / 966 | 24% | 3.68 | 126 / 527 |
ovary | 1% | 2.82 | 2 / 180 | 22% | 1.94 | 94 / 430 |
tonsil | 0% | 0 | 0 / 0 | 20% | 2.53 | 9 / 45 |
adrenal gland | 0% | 1.02 | 1 / 258 | 15% | 1.04 | 34 / 230 |
liver | 0% | 0 | 0 / 226 | 10% | 1.41 | 39 / 406 |
kidney | 8% | 24.06 | 7 / 89 | 1% | 0.43 | 11 / 901 |
spleen | 5% | 14.88 | 13 / 241 | 0% | 0 | 0 / 0 |
adipose | 3% | 17.09 | 41 / 1204 | 0% | 0 | 0 / 0 |
thymus | 1% | 1.91 | 6 / 653 | 2% | 0.16 | 10 / 605 |
peripheral blood | 2% | 6.85 | 21 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 2.19 | 6 / 1335 | 0% | 0 | 0 / 0 |
heart | 0% | 0.69 | 3 / 861 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.67 | 2 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007029 | Biological process | endoplasmic reticulum organization |
GO_0030148 | Biological process | sphingolipid biosynthetic process |
GO_1904220 | Biological process | regulation of serine C-palmitoyltransferase activity |
GO_0046512 | Biological process | sphingosine biosynthetic process |
GO_0046513 | Biological process | ceramide biosynthetic process |
GO_0017059 | Cellular component | serine palmitoyltransferase complex |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005515 | Molecular function | protein binding |
GO_0004758 | Molecular function | serine C-palmitoyltransferase activity |
Gene name | SPTSSB |
Protein name | Serine palmitoyltransferase small subunit B (Protein ADMP) (Small subunit of serine palmitoyltransferase B) (ssSPTb) |
Synonyms | C3orf57 ADMP SSSPTB |
Description | FUNCTION: Component of the serine palmitoyltransferase multisubunit enzyme (SPT) that catalyzes the initial and rate-limiting step in sphingolipid biosynthesis by condensing L-serine and activated acyl-CoA (most commonly palmitoyl-CoA) to form long-chain bases . The SPT complex is composed of SPTLC1, SPTLC2 or SPTLC3 and SPTSSA or SPTSSB. Within this complex, the heterodimer consisting of SPTLC1 and SPTLC2/SPTLC3 forms the catalytic core . Within the SPT complex, SPTSSB stimulates the catalytic activity and plays a role in substrate specificity. SPT complexes with this subunit showing a preference for longer acyl-CoAs. The SPTLC1-SPTLC2-SPTSSB complex shows a strong preference for C18-CoA substrate, while the SPTLC1-SPTLC3-SPTSSB isozyme displays an ability to use a broader range of acyl-CoAs, without apparent preference . . |
Accessions | Q8NFR3 ENST00000497137.1 ENST00000620149.2 ENST00000359175.9 |